Page 177 - Pharmacy Appeals 1/4/04 to 31/3/05
P. 177

NHS Resolution      Annual report and accounts 2021/22                                           153



            8.    Contingent liabilities


                   Ex-RHA            ELS          CNST           DHSC           ELGP         ELSGP
                                                                clinical


                     £ 0 0 0        £ 0 0 0        £ 0 0 0       £ 0 0 0        £ 0 0 0       £ 0 0 0
              Contingent liability as at 31  March 2022

                         0       446,084     70,798,022        939,759             0        670,183


              Restated1contingent liability as at 31  March 2021
                    14,000       348,643     44,302,315        735,414       602,000        392,119



                    CNSGP           CNSC          DHSC            CTIS           PES           LTPS          Total
                                             non-clinical


                     £ 0 0 0        £ 0 0 0        £ 0 0 0       £ 0 0 0        £ 0 0 0       £ 0 0 0        £ 0 0 0
              Contingent liability as at 31  March 2022

                   462,758         54,077       108,543          2,000          9,181       177,015     73,664,622

              Restated contingent liability as at 31  March 2021

                   721,938        43,000         95,522          1 , 0 0 0      5,819       210,267     47,472,037


             NHS  Resolution makes a  provision in its accounts   As a result of the dissolution of NHS primary care trusts

            for the likely value of future claims payments and   and strategic health authorities (on  1 April 2013),  NHS
             records contingent liabilities that represent possible   Resolution  has taken on  responsibility for any outstanding
            claims payments additional to those already provided   criminal liabilities, on  behalf of the Secretary of State
            for. These amounts are not included  in the accounts,   for Health and Social Care. Any valid claims arising
             but shown as a Note to the financial statements     from the activities of those organisations will  be dealt
             because a transfer of economic benefit through      with by NHS  Resolution and funded  in full  by DHSC.
            the payment of damages is not deemed  likely.
                                                                 We have not determined a separate and
            The contingent liability represents an estimation of the   additional contingent liability for Covid-19 risks
            additional  provision  NHS  Resolution would  recognise in   because we have included explicit provisions
             its accounts if damage payments were awarded on all   for the material and quantifiable risks.
            claims, rather than taking  into account the probability
            of damages being  paid (i.e.  reflecting that typically
             many claims settle at nil). The known claims provision
             is calculated as the sum of outstanding reserve values
            (i.e. total claim value less payments) multiplied  by
            the probability of damages being paid, inflated and
            discounted to provide a present value of the claim  based
            on the expected settlement dates. The IBNR provisions
            calculation also includes probabilities of a claim being
             paid for each of the schemes. The contingent liability
             is then the difference between the total valuation
            of IBNR and  known claims (including estimations on
            claims which are ultimately expected to settle at nil)
            and the main valuation of known claims and  IBNR
            (which excludes claims expected to settle at nil).

             The balance at 31  March  2021  for the CNST scheme  has been  increased by £1,392  million to  reflect a  prior period adjustment
              for 2020/21  in  respect of the  revaluation of the  known  claims provision.  See  Note 7.4 for further details of the  revaluation.
   172   173   174   175   176   177   178   179   180   181   182